Gene · 2166
Papers3,784
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,784
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structural basis of the amidase ClbL central to the biosynthesis of the genotoxin colibactin. | Acta Crystallogr D Struct Biol | 2023 | 37561403 | PubTator, text mining | PubMed |
| Fatty Acid Amide Hydrolase, Neurodevelopment, and Alcohol: Illuminating the Intricacies of the Endocannabinoid System in Addiction Susceptibility. | Biol Psychiatry | 2023 | 37558315 | PubTator, text mining | PubMed |
| A cellular overview of immunometabolism in systemic lupus erythematosus. | Oxf Open Immunol | 2023 | 37554724 | PubTator, text mining | PubMed |
| CB1 receptor expression and signaling are required for dexamethasone-induced aversive memory consolidation. | Neuropharmacology | 2023 | 37541383 | PubTator, text mining | PubMed |
| Questioning the role of palmitoylethanolamide in psychosis: a systematic review of clinical and preclinical evidence. | Front Psychiatry | 2023 | 37533892 | PubTator, text mining | PubMed |
| Could cannabinoids provide a new hope for ovarian cancer patients? | Pharmacol Res Perspect | 2023 | 37526235 | PubTator, text mining | PubMed |
| Research Trends and Foci in Osteoarthritis Pain from 2012 to 2022: Bibliometric and Visualization Study. | J Pain Res | 2023 | 37525820 | PubTator, text mining | PubMed |
| A genome-wide association study identifies 41 loci associated with eicosanoid levels. | Commun Biol | 2023 | 37524825 | PubTator, text mining | PubMed |
| N-oleoyl glycine and N-oleoyl alanine attenuate alcohol self-administration and preference in mice. | Transl Psychiatry | 2023 | 37524707 | PubTator, text mining | PubMed |
| Endocannabinoid signaling and epigenetics modifications in the neurobiology of stress-related disorders. | Neuronal Signal | 2023 | 37520658 | PubTator, text mining | PubMed |
| The Skin and Natural Cannabinoids-Topical and Transdermal Applications. | Pharmaceuticals (Basel) | 2023 | 37513960 | PubTator, text mining | PubMed |
| Inhibitors of Endocannabinoids' Enzymatic Degradation as a Potential Target of the Memory Disturbances in an Acute N-Methyl-D-Aspartate (NMDA) Receptor Hypofunction Model of Schizophrenia in Mice. | Int J Mol Sci | 2023 | 37511157 | PubTator, text mining | PubMed |
| Supporting Machine Learning Model in the Treatment of Chronic Pain. | Biomedicines | 2023 | 37509416 | PubTator, text mining | PubMed |
| PheSom: a term frequency-based method for measuring human phenotype similarity on the basis of MeSH vocabulary. | Front Genet | 2023 | 37496714 | PubTator, text mining | PubMed |
| A Randomized, Controlled Trial of Efficacy and Safety of Cannabidiol in Idiopathic and Diabetic Gastroparesis. | Clin Gastroenterol Hepatol | 2023 | 37482172 | PubTator, text mining | PubMed |
| Retinal gliosis and phenotypic diversity of intermediate filament induction and remodeling upon acoustic blast overpressure (ABO) exposure to the rat eye. | Exp Eye Res | 2023 | 37481225 | PubTator, text mining | PubMed |
| Development of Dual Inhibitors of Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase with Tetrazole Core. | Med Chem | 2023 | 37464836 | PubTator, text mining | PubMed |
| Exome-wide evidence of compound heterozygous effects across common phenotypes in the UK Biobank. | medRxiv | 2023 | 37461573 | PubTator, text mining | PubMed |
| An α-hemoglobin-derived peptide (m)VD-hemopressin (α) promotes NREM sleep via the CB1 cannabinoid receptor. | Front Pharmacol | 2023 | 37456761 | PubTator, text mining | PubMed |
| Historic recurrences in medicinal chemistry: nature-inspired structures as a new opportunity for novel multi-target anti-Alzheimer's drugs. | Neural Regen Res | 2023 | 37449616 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2166/papers?page=19